JP2015028094A5 - - Google Patents

Download PDF

Info

Publication number
JP2015028094A5
JP2015028094A5 JP2014231788A JP2014231788A JP2015028094A5 JP 2015028094 A5 JP2015028094 A5 JP 2015028094A5 JP 2014231788 A JP2014231788 A JP 2014231788A JP 2014231788 A JP2014231788 A JP 2014231788A JP 2015028094 A5 JP2015028094 A5 JP 2015028094A5
Authority
JP
Japan
Prior art keywords
pharmaceutical
oral
layer
zaleplon
polymer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014231788A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015028094A (ja
JP6104873B2 (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2015028094A publication Critical patent/JP2015028094A/ja
Publication of JP2015028094A5 publication Critical patent/JP2015028094A5/ja
Application granted granted Critical
Publication of JP6104873B2 publication Critical patent/JP6104873B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014231788A 2008-12-04 2014-11-14 ザレプロン胃内滞留性薬剤送達システム Expired - Fee Related JP6104873B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12005108P 2008-12-04 2008-12-04
US61/120,051 2008-12-04

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2011539117A Division JP2012510987A (ja) 2008-12-04 2009-10-19 ザレプロン胃内滞留性薬剤送達システム

Publications (3)

Publication Number Publication Date
JP2015028094A JP2015028094A (ja) 2015-02-12
JP2015028094A5 true JP2015028094A5 (enExample) 2015-12-10
JP6104873B2 JP6104873B2 (ja) 2017-03-29

Family

ID=42232930

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2011539117A Pending JP2012510987A (ja) 2008-12-04 2009-10-19 ザレプロン胃内滞留性薬剤送達システム
JP2014231788A Expired - Fee Related JP6104873B2 (ja) 2008-12-04 2014-11-14 ザレプロン胃内滞留性薬剤送達システム

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2011539117A Pending JP2012510987A (ja) 2008-12-04 2009-10-19 ザレプロン胃内滞留性薬剤送達システム

Country Status (11)

Country Link
US (2) US9693981B2 (enExample)
EP (1) EP2378883B1 (enExample)
JP (2) JP2012510987A (enExample)
KR (1) KR20110116004A (enExample)
CN (1) CN102300463B (enExample)
CA (1) CA2745741A1 (enExample)
ES (1) ES2562925T3 (enExample)
IL (1) IL213376A (enExample)
PL (1) PL2378883T3 (enExample)
WO (2) WO2010064100A1 (enExample)
ZA (1) ZA201104620B (enExample)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2606395T3 (es) 2008-04-18 2017-03-23 Intec Pharma Ltd. Administración de fármacos gastrorretentivos para carbidopa/levodopa
UA108211C2 (uk) * 2009-11-04 2015-04-10 Янссен Рід Айрленд Бензімідазолімідазольні похідні
US20130078290A1 (en) * 2010-06-01 2013-03-28 Rubicon Research Private Limited Gastroretentive Dosage Forms Of GABA Analogs
US9248111B2 (en) 2011-03-01 2016-02-02 Pharnext Therapeutic approaches for treating parkinson's disease
ES2665569T3 (es) * 2011-03-01 2018-04-26 Pharnext Tratamiento de la isquemia cerebral
US9180108B2 (en) 2011-10-27 2015-11-10 Medtronic, Inc. Baclofen formulations and methods for making same
US20130143867A1 (en) 2011-12-02 2013-06-06 Sychroneuron Inc. Acamprosate formulations, methods of using the same, and combinations comprising the same
US9622997B2 (en) 2012-06-01 2017-04-18 Lynn Health Science Institute, Inc. Methods for treating insomnia
WO2014039951A1 (en) * 2012-09-10 2014-03-13 Novartis Ag Enteral pharmaceutical compositions
CN105431144A (zh) 2013-06-05 2016-03-23 思康脑侒股份有限公司 阿坎酸制剂、使用阿坎酸制剂的方法以及包含阿坎酸制剂的组合
US9566248B2 (en) 2013-09-13 2017-02-14 R.P. Scherer Technologies, Llc Encased-pellet tablets
FR3014692B1 (fr) * 2013-12-18 2016-01-29 Ethypharm Sa Compositions pharmaceutiques orales a retention gastrique.
JP6666858B2 (ja) 2014-06-11 2020-03-18 マサチューセッツ インスティテュート オブ テクノロジー 滞留構造体および関連方法
US20170266112A1 (en) 2014-06-11 2017-09-21 Massachusetts Institute Of Technology Residence structures and related methods
WO2016109412A1 (en) * 2014-12-29 2016-07-07 Boston Scientific Scimed, Inc. Compositions, devices and methods for multi-stage release of chemotherapeutics
US10172800B2 (en) 2015-02-20 2019-01-08 Osmotica Kereskedelmi Es Szolgaltato Kft Controlled release dosage form with enhanced pharmacokinetics
US10987328B2 (en) 2015-02-20 2021-04-27 Osmotica Kereskedelmi Es Szolgaltato Kft Controlled release dosage form
EP3258914A1 (en) 2015-02-20 2017-12-27 Osmotica Kereskedelmi ES Szolgaltato KFT Controlled release oral dosage form of gaba receptor agonist
US10300032B2 (en) 2015-02-20 2019-05-28 Osmotica Kereskedelmi Es Szolgaltato Kft Controlled release dosage form
CN118975972A (zh) 2015-10-23 2024-11-19 林德拉治疗公司 用于治疗剂缓释的胃驻留系统及其使用方法
US9849125B1 (en) 2015-11-03 2017-12-26 Banner Lifie Sciences LLC Anti-overingestion dosage forms
BR112018011636B1 (pt) 2015-12-08 2024-03-12 Lyndra Therapeutics, Inc Sistema de residência gástrico para liberação sustentada de um agente terapêutico
CN119925721A (zh) 2016-05-27 2025-05-06 林德拉治疗公司 用于胃驻留系统的材料结构
EP3481371A1 (en) * 2016-07-11 2019-05-15 Intec Pharma Ltd. Oral gastroretentive formulations and uses thereof
CN110022861B (zh) 2016-09-30 2024-06-28 林德拉治疗公司 用于金刚烷类药物缓释的胃驻留系统
CA3060026A1 (en) * 2017-04-18 2018-10-25 Jayant Jagannath Khandare Polymer based formulation for release of drugs and bioactives at specific git sites
US10335375B2 (en) 2017-05-30 2019-07-02 Patheon Softgels, Inc. Anti-overingestion abuse deterrent compositions
AU2018279853B2 (en) 2017-06-09 2024-07-04 Lyndra Therapeutics, Inc. Gastric residence systems with release rate-modulating films
JP7458317B2 (ja) 2017-10-31 2024-03-29 サムヤン、ホールディングス、コーポレーション 崩壊が改善された経口用固形製剤組成物及びその製造方法
EP3941445A4 (en) 2019-03-20 2023-08-02 Lyndra Therapeutics, Inc. CAPSULES AND CAPSULE COATINGS FOR GASOLINE DOSAGE FORMS
EP3941444B1 (en) * 2019-03-20 2025-03-26 Lyndra Therapeutics, Inc. Coatings for gastric residence dosage forms
US10792262B1 (en) 2019-07-29 2020-10-06 Saol International Limited Stabilized formulations of 4-amino-3-substituted butanoic acid derivatives
US11654124B2 (en) 2019-07-29 2023-05-23 Amneal Pharmaceuticals Llc Stabilized formulations of 4-amino-3-substituted butanoic acid derivatives
US20220409539A1 (en) * 2019-12-30 2022-12-29 Fraunhofer Usa Inc. Particles for multi-dose delivery
US11491125B1 (en) * 2021-09-29 2022-11-08 Amneal Pharmaceuticals Llc Baclofen formulations and methods of minimizing patient exposure to metabolite variations
CA3248763A1 (en) * 2022-01-19 2023-07-27 Lyndra Therapeutics Inc Pharmaceutical forms for gastric retention

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4451260A (en) * 1982-03-26 1984-05-29 Minnesota Mining And Manufacturing Company Sustained release oral medicinal delivery device
US4767627A (en) 1985-05-29 1988-08-30 Merck & Co., Inc. Drug delivery device which can be retained in the stomach for a controlled period of time
JPH07179334A (ja) * 1993-12-22 1995-07-18 Sanei Touka Kk カプセル及びカプセル剤の製造方法
US5780055A (en) * 1996-09-06 1998-07-14 University Of Maryland, Baltimore Cushioning beads and tablet comprising the same capable of forming a suspension
US20010055613A1 (en) 1998-10-21 2001-12-27 Beth A. Burnside Oral pulsed dose drug delivery system
EP1064937A1 (en) * 1999-06-28 2001-01-03 Sanofi-Synthelabo Timed dual release dosage forms comprising a short acting hypnotic or a salt thereof
US6485746B1 (en) * 2000-08-25 2002-11-26 Neurocrine Biosciences, Inc. Controlled-release sedative-hypnotic compositions and methods related thereto
IL133196A0 (en) * 1999-11-29 2001-03-19 Yissum Res Dev Co Gastroretentive controlled release pharmaceutical dosage forms
DE10004790B4 (de) 2000-02-01 2004-09-09 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System zur Verabreichung von Zaleplon, Verfahren zu seiner Herstellung und seine Verwendung
CA2452738C (en) 2001-07-04 2011-06-14 Sun Pharmaceutical Industries Limited Gastric retention controlled drug delivery system
US20080081834A1 (en) * 2002-07-31 2008-04-03 Lippa Arnold S Methods and compositions employing bicifadine for treating disability or functional impairment associated with acute pain, chronic pain, or neuropathic disorders
US7985422B2 (en) * 2002-08-05 2011-07-26 Torrent Pharmaceuticals Limited Dosage form
US20050038042A1 (en) * 2002-11-15 2005-02-17 Jenet Codd Modified release composition comprising a short-acting hypnotic for treatment of sleep disorders
CA2510465A1 (en) * 2002-12-18 2004-07-08 Pain Therapeutics Oral dosage forms with therapeutically active agents in controlled release cores and immediate release gelatin capsule coats
KR100553887B1 (ko) * 2003-06-24 2006-02-24 삼성전자주식회사 수직 및 수평으로 광시야각을 갖는 영상표시용 스크린 및이를 구비하는 프로젝션 텔레비전
US20050090554A1 (en) * 2003-09-12 2005-04-28 John Devane Treatment of gastroparesis and nonulcer dyspepsia with GABAB agonists
EP1523981A1 (en) 2003-10-13 2005-04-20 Wyeth Extended release formulations of venlafaxine
EP1686976A2 (en) * 2003-11-05 2006-08-09 Santarus, Inc. Combination of proton pump inhibitor and sleep aid
EP1535952B1 (en) * 2003-11-28 2013-01-16 Universite Louis Pasteur Method for preparing crosslinked polyelectrolyte multilayer films
US20050220874A1 (en) * 2004-04-02 2005-10-06 Chien-Hsuan Han Pharmaceutical dosage forms having immediate release and controlled release properties that contain a GABAB receptor agonist
JP4756835B2 (ja) * 2004-07-14 2011-08-24 キヤノン株式会社 生化学反応カートリッジ
AU2006261893A1 (en) * 2005-06-23 2007-01-04 Combinatorx, Incorporated Improved dosage forms for movement disorder treatment
CA2634869C (en) * 2005-12-23 2012-03-06 Cadbury Adams Usa Llc Compositions providing a sensation substantially similar to that provided by menthol
US8298574B2 (en) 2006-01-18 2012-10-30 Intec Pharma Ltd. Method and apparatus for forming delivery devices for oral intake of an agent
CA2642479C (en) 2006-02-15 2014-08-19 Intec Pharma Ltd. A gastro-retentive system for the delivery of macromolecules
US8765178B2 (en) * 2006-07-19 2014-07-01 Watson Laboratories, Inc. Controlled release formulations and associated methods
ES2365574T3 (es) * 2007-01-11 2011-10-07 Xenoport, Inc. Formas de dosificación oral para liberación continua de un profármaco de r-baclofeno y procedimientos de tratamiento.
EP1970056A1 (en) 2007-03-15 2008-09-17 Polichem S.A. Time-specific delayed/pulsatile release dosage forms
US20100137442A2 (en) * 2008-02-01 2010-06-03 Xenoport, Inc. Sustained Release Particulate Oral Dosage Forms of (R)-Baclofen and Methods of Treatment

Similar Documents

Publication Publication Date Title
JP2015028094A5 (enExample)
JP2012510987A5 (enExample)
JP6815358B2 (ja) 時限パルス放出システム
CN102300463B (zh) 扎来普隆(zaleplon)胃滞留药物传递系统
JP2018536007A5 (enExample)
JP2017019858A5 (enExample)
Zema et al. Gastroresistant capsular device prepared by injection molding
JP2011519967A5 (enExample)
JP2007528901A5 (enExample)
JP7041333B2 (ja) 放出調節コーティングカプセル
JP2016525572A5 (enExample)
TW200936186A (en) Pharmaceutical formulations
JP2016539953A5 (enExample)
JP7041334B2 (ja) 放出調節コーティングカプセル
JP2018536007A (ja) 胃保持性装置
JP2009502908A (ja) ｐＨ制御パルス送達システム、その調製法及び使用法
ES2546172T3 (es) Forma de dosificación para la liberación modificada de betahistina
JP5698683B2 (ja) 治療薬のパルス放出組成物
EP3866758B1 (en) Softgels with solid or gel-like polymeric fill matrix
JP6294457B2 (ja) 低減した送達変動性のための複数の投薬要素を備えるメサラミン医薬組成物
JP2017530990A (ja) 口腔粘膜フィルム製剤
Benzine Enzymatically triggered polymeric drug delivery systems for colon targeting
CN103735528B (zh) 盐酸曲美他嗪双层渗透泵控释片及制备方法
JP6454630B2 (ja) ｐＨ制御パルス送達システム、その調製法及び使用法
JP2018172363A (ja) 腸溶性組成物中に含まれる薬物塩の溶出性を改善する方法